These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8740 related articles for article (PubMed ID: 18376462)

  • 21. [Assessment of tumour angiogenesis using contrast-enhanced ultrasound].
    Cosgrove D; Lassau N
    J Radiol; 2009 Jan; 90(1 Pt 2):156-64. PubMed ID: 19212283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Science to practice: Will improved assessment of response to antiangiogenic therapies be achieved with contrast-enhanced gray-scale US?
    Kruskal JB
    Radiology; 2006 Jul; 240(1):1-2. PubMed ID: 16793969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can the effect of antiangiogenic treatments be monitored and quantified noninvasively by using contrast-enhanced US?
    Forsberg F
    Radiology; 2010 Feb; 254(2):317-8. PubMed ID: 20093504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
    Marzola P; Degrassi A; Calderan L; Farace P; Nicolato E; Crescimanno C; Sandri M; Giusti A; Pesenti E; Terron A; Sbarbati A; Osculati F
    Clin Cancer Res; 2005 Aug; 11(16):5827-32. PubMed ID: 16115922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood flow changes in hepatocellular carcinoma after the administration of thalidomide assessed by reperfusion kinetics during microbubble infusion: preliminary results.
    Bertolotto M; Pozzato G; Crocè LS; Nascimben F; Gasparini C; Cova MA; Tiribelli C
    Invest Radiol; 2006 Jan; 41(1):15-21. PubMed ID: 16355035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perfusion CT and US of colorectal cancer liver metastases: a correlative study of two dynamic imaging modalities.
    Meijerink MR; van Waesberghe JH; van Schaik C; Boven E; van der Veldt AA; van den Tol P; Meijer S; van Kuijk C
    Ultrasound Med Biol; 2010 Oct; 36(10):1626-36. PubMed ID: 20800954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermediate and advanced hepatocellular carcinoma treated with the antiangiogenic agent sorafenib. Evaluation with unenhanced and contrast-enhanced ultrasonography.
    Moschouris H; Malagari K; Gkoutzios P; Kalokairinou M; Stamatiou K; Chatzimichail K; Kornezos I; Karagiannis E; Kiltenis M; Papadaki MG
    Med Ultrason; 2012 Jun; 14(2):87-94. PubMed ID: 22675707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can contrast-enhanced US with targeted microbubbles monitor the response to antiangiogenic therapies?
    Kruskal JB
    Radiology; 2008 Feb; 246(2):339-40. PubMed ID: 18227533
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of early response to antiangiogenic treatment with dynamic contrast enhanced ultrasound].
    Lassau N; Brule A; Chami L; Benatsou B; Péronneau P; Roche A
    J Radiol; 2008 May; 89(5 Pt 1):549-55. PubMed ID: 18535495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification--preliminary results.
    Lassau N; Koscielny S; Chami L; Chebil M; Benatsou B; Roche A; Ducreux M; Malka D; Boige V
    Radiology; 2011 Jan; 258(1):291-300. PubMed ID: 20980447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of microvascular perfusion changes in a rat breast tumor model using SonoVue to monitor the effects of different anti-angiogenic therapies.
    Broillet A; Hantson J; Ruegg C; Messager T; Schneider M
    Acad Radiol; 2005 May; 12 Suppl 1():S28-33. PubMed ID: 16106543
    [No Abstract]   [Full Text] [Related]  

  • 32. [Preoperative sonovue contrast color Doppler in patients with cervical cancer. Preliminary report].
    Malinova M
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():11-6. PubMed ID: 24294739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perfusion curve f (t) analysis of breast cancer by contrast-enhanced ultrasonography.
    Guo L; Liu ZG; Han PH; Yuan Q; He Y; Li J
    Acta Radiol; 2012 Nov; 53(9):981-6. PubMed ID: 22969089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast enhanced ultrasonography (CEUS) in the characterization of tumor microcirculation. Validation of the procedure in the animal experimental model.
    Badea AF; Tamas-Szora A; Clichici S; Socaciu M; Tăbăran AF; Băciut G; Cătoi C; Mureşan A; Buruian M; Badea R
    Med Ultrason; 2013 Jun; 15(2):85-94. PubMed ID: 23702496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular targeting tumor therapy: non-invasive contrast enhanced ultrasound for quantitative assessment of tumor microcirculation.
    Eichhorn ME; Klotz LV; Luedemann S; Strieth S; Kleespies A; Preissler G; Lindner M; Jauch KW; Reiser MF; Clevert DA
    Cancer Biol Ther; 2010 May; 9(10):794-802. PubMed ID: 20234173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic contrast-enhanced MRI for oncology drug development.
    Sung YS; Park B; Choi Y; Lim HS; Woo DC; Kim KW; Kim JK
    J Magn Reson Imaging; 2016 Aug; 44(2):251-64. PubMed ID: 26854494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative perfusion analysis of malignant liver tumors: dynamic computed tomography and contrast-enhanced ultrasound.
    Goetti R; Reiner CS; Knuth A; Klotz E; Stenner F; Samaras P; Alkadhi H
    Invest Radiol; 2012 Jan; 47(1):18-24. PubMed ID: 21788906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of contrast-enhanced ultrasound with two distinct types of blood vessels for the assessment of angiogenesis in lewis lung carcinoma.
    Zhuo J; Fu W; Liu S
    Ultraschall Med; 2014 Oct; 35(5):468-72. PubMed ID: 24327471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-dimensional Dynamic Contrast-enhanced US Imaging for Early Antiangiogenic Treatment Assessment in a Mouse Colon Cancer Model.
    Wang H; Hristov D; Qin J; Tian L; Willmann JK
    Radiology; 2015 Nov; 277(2):424-34. PubMed ID: 26020439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measuring tumor perfusion in control and treated murine tumors: correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography.
    Niermann KJ; Fleischer AC; Huamani J; Yankeelov TE; Kim DW; Wilson WD; Hallahan DE
    J Ultrasound Med; 2007 Jun; 26(6):749-56. PubMed ID: 17526606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 437.